Annual Working Capital
$1.82 M
+$893.60 K+96.16%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual working capital is $1.82 million, with the most recent change of +$893.60 thousand (+96.16%) on December 31, 2023.
- During the last 3 years, ENTO annual working capital has risen by +$9.50 million (+123.75%).
- ENTO annual working capital is now at all-time high.
Performance
ENTO Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$68.15 M
-$850.20 K-1.23%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly working capital is $68.15 million, with the most recent change of -$850.20 thousand (-1.23%) on September 1, 2024.
- Over the past year, ENTO quarterly working capital has increased by +$66.33 million (+3638.66%).
- ENTO quarterly working capital is now -1.23% below its all-time high of $69.00 million, reached on June 30, 2024.
Performance
ENTO Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
ENTO Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +96.2% | +3638.7% |
| 3 y3 years | +123.8% | +7430.6% |
| 5 y5 years | +1.0% | +3361.3% |
ENTO Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +163.4% | -1.2% | +539.8% |
| 5 y | 5-year | at high | +123.8% | -1.2% | +539.8% |
| alltime | all time | at high | +123.8% | -1.2% | +539.8% |
Entero Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $68.15 M(-1.2%) |
| Jun 2024 | - | $69.00 M(+5140.5%) |
| Mar 2024 | - | $1.32 M(-27.8%) |
| Dec 2023 | $1.82 M(+96.2%) | $1.82 M(+22.0%) |
| Sep 2023 | - | $1.49 M(-264.7%) |
| Jun 2023 | - | -$907.40 K(-200.3%) |
| Mar 2023 | - | $905.00 K(-2.6%) |
| Dec 2022 | $929.30 K(-132.3%) | - |
| Dec 2022 | - | $929.30 K(-122.4%) |
| Sep 2022 | - | -$4.15 M(-73.2%) |
| Jun 2022 | - | -$15.49 M(+102.1%) |
| Mar 2022 | - | -$7.67 M(+166.6%) |
| Dec 2021 | -$2.88 M(-62.5%) | -$2.88 M(-75.2%) |
| Sep 2021 | - | -$11.60 M(-636.5%) |
| Jun 2021 | - | $2.16 M(-77.5%) |
| Mar 2021 | - | $9.60 M(-225.0%) |
| Dec 2020 | -$7.68 M | -$7.68 M(-186.1%) |
| Sep 2020 | - | $8.91 M(-248.2%) |
| Jun 2020 | - | -$6.01 M(+167.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | -$2.25 M(+156.0%) |
| Dec 2019 | -$877.30 K(-148.6%) | -$877.30 K(-58.0%) |
| Sep 2019 | - | -$2.09 M(-19.4%) |
| Jun 2019 | - | -$2.59 M(-12.2%) |
| Mar 2019 | - | -$2.95 M(-263.7%) |
| Dec 2018 | $1.80 M(-442.7%) | $1.80 M(-57.2%) |
| Sep 2018 | - | $4.22 M(-30.0%) |
| Jun 2018 | - | $6.02 M(-694.3%) |
| Mar 2018 | - | -$1.01 M(+92.5%) |
| Dec 2017 | -$526.50 K(-184.5%) | -$526.50 K(-216.0%) |
| Sep 2017 | - | $453.90 K(-81.6%) |
| Jun 2017 | - | $2.47 M(-373.8%) |
| Mar 2017 | - | -$902.60 K(-244.8%) |
| Dec 2016 | $623.20 K(-109.2%) | $623.20 K(-104.4%) |
| Sep 2016 | - | -$14.19 M(+17.7%) |
| Jun 2016 | - | -$12.06 M(+41.2%) |
| Mar 2016 | - | -$8.54 M(+26.6%) |
| Dec 2015 | -$6.75 M(+281.8%) | -$6.75 M |
| Dec 2014 | -$1.77 M | - |
FAQ
- What is Entero Therapeutics annual working capital?
- What is the all time high annual working capital for Entero Therapeutics?
- What is Entero Therapeutics annual working capital year-on-year change?
- What is Entero Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Entero Therapeutics?
- What is Entero Therapeutics quarterly working capital year-on-year change?
What is Entero Therapeutics annual working capital?
The current annual working capital of ENTO is $1.82 M
What is the all time high annual working capital for Entero Therapeutics?
Entero Therapeutics all-time high annual working capital is $1.82 M
What is Entero Therapeutics annual working capital year-on-year change?
Over the past year, ENTO annual working capital has changed by +$893.60 K (+96.16%)
What is Entero Therapeutics quarterly working capital?
The current quarterly working capital of ENTO is $68.15 M
What is the all time high quarterly working capital for Entero Therapeutics?
Entero Therapeutics all-time high quarterly working capital is $69.00 M
What is Entero Therapeutics quarterly working capital year-on-year change?
Over the past year, ENTO quarterly working capital has changed by +$66.33 M (+3638.66%)